Kodak and Imation keep quiet on rumors
Ongoing rumors about the possibility of a business deal between x-ray film companies Eastman Kodak of Rochester, NY, and Imation of Oakdale, MN, aren't drawing any comment from either of the firms. The rumors have hinted that Kodak might buy part of
Ongoing rumors about the possibility of a business deal between x-ray film companies Eastman Kodak of Rochester, NY, and Imation of Oakdale, MN, aren't drawing any comment from either of the firms. The rumors have hinted that Kodak might buy part of Imation, such as the company's medical imaging business, which includes dry printers, x-ray film, and PACS operations.
Speculation about a possible deal has surfaced on online investment boards and was rife on the exhibit floor at last month's American Healthcare Radiology Administrator's meeting in Las Vegas. Representatives from both Kodak and Imation said that as a matter of corporate policy the companies do not comment on rumors.
If Kodak did buy Imation's medical imaging business, the deal would give Kodak an even stronger position in the x-ray film and PACS markets. Rumors about Kodak have proven wrong in the past, however. Speculation late last year that Kodak would sell its medical imaging business to Johnson & Johnson proved to be untrue (SCAN 1/21/98).
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
